Genocea to Present at the H.C. Wainwright Virtual BioConnect Conference
January 04, 2021 at 16:18 PM EST
CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect Conference being held from January 11 – 14, 2021. A webcast of the on-demand presentation will be available on the investor section of the Genocea website at http://ir.genocea.com, beginning on Monday, January 11, 2021.
Following the conclusion of the conference, the presentation will remain archived on the Genocea website for approximately 90 days.
About Genocea Biosciences, Inc.